Alia Khaled

Health Economics and Market Access, Biosense Webster, Inc., Irvine, CA, USA, Canada

Poster(s):

• (B-176) Catheter ablation versus antiarrhythmic drugs for treatment of atrial fibrillation in patients with concomitant heart failure with preserved ejection fraction (HFpEF)
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET